The latest announcement is out from Morphic Holding (MORF).
Amidst a significant corporate restructuring following a merger, a company has terminated multiple stock and equity plans and ended a sales agreement for an at-the-market offering program. Additionally, they have notified Nasdaq about the merger, requested the suspension of their common stock trading, and initiated the delisting process. There’s also been a complete overhaul of the board of directors and executive officers, with all previous members resigning and new directors and officers stepping in from the purchasing company, aligning with the terms of the merger agreement. The company’s certificate of incorporation and bylaws have been amended to reflect these comprehensive changes.
Learn more about MORF stock on TipRanks’ Stock Analysis page.
